The conect4children (c4c) Consortium: Potential for Improving European Clinical Research into Medicines for Children Mark A. TurnerHeidrun HildebrandCarlo Giaquinto Leading Article Open access 04 February 2021 Pages: 71 - 79
Impact of Advantage in Tumor Response on the Correlation Between Progression-Free Survival and Overall Survival: Meta-Analysis of Clinical Trials in Patients with Advanced Non-Small Cell Lung Cancer Yosuke YoshidaMasayuki KanekoMamoru Narukawa Systematic Review 23 January 2021 Pages: 81 - 92
Regulatory Approval Scenario of Biosimilars in Pediatric Patients in the United States and European Union Swetha RadhakrishnaMeghana DahiyaVinu Jose Review Article 17 February 2021 Pages: 93 - 112
The Qualitative Value of Facilitated Regulatory Pathways in Europe, USA, and Japan: Benefits, Barriers to Utilization, and Suggested Solutions Magdalena BujarNeil McAuslaneLawrence Liberti Original Research Article Open access 04 February 2021 Pages: 113 - 122
Evaluating the Effectiveness of Apixaban Additional Risk Minimisation Measures Using Surveys in Europe Steve MayallRandip KahlonSophie W Shen Original Research Article Open access 04 March 2021 Pages: 123 - 135
Klaus Rose. Considering the Patient in Pediatric Drug Development: How Good Intentions Turned into Harm Pasquale Striano Book Review 22 January 2021 Pages: 137 - 138
Major Pharmaceutical Conferences and Courses: June to July 2021 Update 07 February 2021 Pages: 139 - 141
